Clinical Study
Retrobulbar Hemodynamic Effects of Nipradilol in Normal and Normal-Tension Glaucoma Eyes
Table 1
Systemic and ocular parameters before and after topical application of nipradilol or placebo in controls.
| | Parameter | Nipradilol | Placebo | | Before | 2 hrs () | 1 week () | Before | 2 hrs () | 1 week () |
| | Intraocular pressure (mmHg) | | (0.0047)* | (0.0071)* | | (0.1212) | (0.0144)* | | Blood pressure | | | | | | | | Systolic (mmHg) | | (0.6542) | (0.7550) | | (0.6542) | (0.7550) | | Diastolic (mmHg) | | (0.9591) | (0.8584) | | (0.9591) | (0.8584) | | Heart rate (beats/min) | | (0.1967) | (0.1379) | | (0.1967) | (0.1379) | | Ocular perfusion pressure (mmHg) | | (0.0505) | (0.2477) | | (0.3281) | (0.4496) |
|
|
Wilcoxon signed-rank sum test.
Values are presented as mean ± standard deviation.
.
|
